LITE STRATEGY INC (LITS) Stock Overview
USA - NASDAQ:LITS - US55279B3015 - Common Stock
LITS Key Statistics, Chart & Performance
The current stock price of LITS is 2.93 USD.
LITS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.62 | 385.71B | ||
| AMGN | AMGEN INC | 12.67 | 148.80B | ||
| GILD | GILEAD SCIENCES INC | 14.8 | 142.13B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.29 | 101.15B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 61.07B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.27 | 59.35B | ||
| ARGX | ARGENX SE - ADR | 81.59 | 46.29B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.67 | 38.56B | ||
| INSM | INSMED INC | N/A | 30.85B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.26B | ||
| NTRA | NATERA INC | N/A | 23.13B | ||
| BIIB | BIOGEN INC | 9.05 | 21.24B |
Related stock screener links
About LITS
Company Profile
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. The company is headquartered in San Diego, California and currently employs 28 full-time employees. The company went IPO on 2003-12-18. The firm's treasury initiative is anchored by Litecoin. The firm has discontinued the clinical development of voruciclib, while certain nonclinical activities related to its drug candidate assets continue to be conducted by it. As part of the review of strategic alternatives, the Company may consider options such as out-licensing opportunities for existing programs and merger and acquisition opportunities.
Company Info
LITE STRATEGY INC
9920 Pacific Heights Blvd, Suite 150
San Diego CALIFORNIA US
Employees: 28
Phone: 18583697100
LITE STRATEGY INC / LITS FAQ
What is the stock price of LITE STRATEGY INC today?
The current stock price of LITS is 2.93 USD.
What is the ticker symbol for LITE STRATEGY INC stock?
The exchange symbol of LITE STRATEGY INC is LITS and it is listed on the Nasdaq exchange.
On which exchange is LITS stock listed?
LITS stock is listed on the Nasdaq exchange.
What is LITE STRATEGY INC worth?
LITE STRATEGY INC (LITS) has a market capitalization of 96.22M USD. This makes LITS a Micro Cap stock.
How many employees does LITE STRATEGY INC have?
LITE STRATEGY INC (LITS) currently has 28 employees.
Should I buy LITE STRATEGY INC (LITS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of LITS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of LITS, evaluating the profitability, health, valuation and growth aspects
- LITE STRATEGY INC (LITS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- LITE STRATEGY INC (LITS) Sales and EPS estimates to see what analysts future expectations are.
- LITE STRATEGY INC (LITS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- LITE STRATEGY INC (LITS) Insider and Institutional Ownership to learn about the owners and their transactions.
- LITE STRATEGY INC (LITS) Stock Chart to make your own analysis
- LITE STRATEGY INC (LITS) Latest news and press-releases to stay up to date.
Does LITE STRATEGY INC (LITS) stock pay dividends?
LITS does not pay a dividend.
When does LITE STRATEGY INC (LITS) report earnings?
LITE STRATEGY INC (LITS) will report earnings on 2025-09-17, after the market close.
LITS Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to LITS.
LITS Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |